Bevacizumab - Biosimilars Insight, 2024
Bevacizumab, a monoclonal antibody developed by Genentech and marketed under the brand name Avastin, has been a significant player in the oncology landscape since its approval. It is primarily used for treating various cancers, including metastatic colorectal cancer, non-small cell lung cancer, and glioblastoma multiforme. The drug works by...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian